These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Introduction. Reboxetine: a new selective antidepressant for the treatment of depression. Montgomery SA; Schatzberg AF J Clin Psychiatry; 1998; 59 Suppl 14():3. PubMed ID: 9818622 [No Abstract] [Full Text] [Related]
23. [Critical comments on the methods of assessing the effectiveness of antidepressive pharmacotherapy]. Maier W; Benkert O Nervenarzt; 1987 Oct; 58(10):595-602. PubMed ID: 3317081 [No Abstract] [Full Text] [Related]
24. Interaction of EEG sleep, antidepressants, and affective disease. Kupfer D J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):30-6. PubMed ID: 6217197 [TBL] [Abstract][Full Text] [Related]
25. [Identification of antidepressants based on the characteristics of EEG spatial organization]. Monakhov KK; Paniushkina SV; Bochkarev VK; Nazmutdinov IG Farmakol Toksikol; 1987; 50(4):25-9. PubMed ID: 3666113 [TBL] [Abstract][Full Text] [Related]
26. [Pharmacotherapy of depressive syndromes in childhood and adolescence]. Schulz E; Remschmidt H Z Kinder Jugendpsychiatr; 1988 Sep; 16(3):142-54. PubMed ID: 3055741 [No Abstract] [Full Text] [Related]
29. New antidepressants and trends in the pharmacotherapy of depressive disorders. Zarifian E; Rigal F Psychiatr Clin North Am; 1983 Mar; 6(1):129-39. PubMed ID: 6889169 [No Abstract] [Full Text] [Related]
30. [Drug resistance in endogenous depression. Part I. Refractoriness to antidepressants in patients with depression admitted to a psychiatric clinic for the first time]. Puzyński S; Koszewska I; Kalinowski A; Bogdanowicz E; Swiecicki L Psychiatr Pol; 1993; 27(6):673-82. PubMed ID: 8134501 [TBL] [Abstract][Full Text] [Related]
31. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. III. Analysis of the factors affecting the effectiveness of treatment with thymoleptics]. Twarowska-Hauser J; Strzyzewski W Psychiatr Pol; 1985; 19(5):370-5. PubMed ID: 3913977 [No Abstract] [Full Text] [Related]
32. [Biological treatment of depression]. Colonna L Rev Prat; 1999 Apr; 49(7):733-8. PubMed ID: 10337218 [TBL] [Abstract][Full Text] [Related]
33. Endogenous depression: biochemical determinants and drug treatment. Hollister LE Drug Ther; 1982; ():81-98. PubMed ID: 7049653 [No Abstract] [Full Text] [Related]
34. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. II. Comparison of the effects of various thymoleptics on the psychopathological symptoms of endogenous depressive syndromes]. Strzyzewski W; Twarowska-Hauser J; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E Psychiatr Pol; 1985; 19(5):363-9. PubMed ID: 3913976 [No Abstract] [Full Text] [Related]
38. Transition to depression? Perimenopause, menopause and mental health. Antai-Otong D Adv Nurse Pract; 2007 Oct; 15(10):45-6, 48-50. PubMed ID: 19998879 [No Abstract] [Full Text] [Related]
39. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. I. Analysis of the clinical effect of antidepressive drugs with various pharmacological profiles]. Twarowska-Hauser J; Strzyzewksi W; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E Psychiatr Pol; 1985; 19(5):357-62. PubMed ID: 3913975 [No Abstract] [Full Text] [Related]
40. Drug treatment of depression. Adams J N Z Med J; 1993 May; 106(956):208-9. PubMed ID: 8341441 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]